Welcome to Clinical Trial Confidential.

We believe the clinical trial industry lacks a platform for open, transparent conversation. This lack of transparency inhibits progress. In this industry, that means patients are the ones that suffer.

Here you can choose to register an account, post anonymously or both. It is our hope that the ability to post anonymously will help foster useful conversation by allowing users to express their opinions without fear of retaliation, fear of appearing ignorant and otherwise allowing users to express opinions that may be contrary to their employer or that their position may not permit.

We believe great ideas should stand on their own merit and not the credentials of their author.

We hope these values will foster an environment of collaboration.

Forum breadcrumbs - You are here:ForumTopics: Sponors/CROsBioHaven

BioHaven

Reply
brad@brad
184 Posts
#1 · May 3, 2022, 1:31 am
Quote

Anyone working on any of their studies? Would love to connect and discuss.

Click for thumbs down.0Click for thumbs up.0
Hightower Clinical / Note to File Podcast / Existential Dilettante / "Specialization is for insects"
Guest
#2 · May 3, 2022, 3:28 pm
Quote

Their OCD study has incredibly difficult i/e criteria and is a money loser.  https://clinicaltrials.gov/ct2/show/NCT04641143

I guess they don't see a point in designing a recruitable phase 3 trial (or spending big to make it still work) for a drug that failed phase 2.  https://www.spglobal.com/marketintelligence/en/news-insights/blog/banking-essentials-april-13-2022

Click for thumbs down.0Click for thumbs up.1
brad@brad
184 PostsTopic Author
#3 · May 3, 2022, 3:37 pm
Quote

We're working on a migraine study but it's been a real mess.

Have had a great experience with them before but this time around is really terrible.

Click for thumbs down.0Click for thumbs up.1
Hightower Clinical / Note to File Podcast / Existential Dilettante / "Specialization is for insects"
Guest
#4 · May 10, 2022, 1:06 pm
Quote

We've just started a migraine study with them. What problems are you having? I'm the backup coordinator, but I can pass along information.

Click for thumbs down.0Click for thumbs up.0
brad@brad
184 PostsTopic Author
#5 · May 10, 2022, 1:48 pm
Quote
Quote from Guest on May 10, 2022, 1:06 pm

We've just started a migraine study with them. What problems are you having? I'm the backup coordinator, but I can pass along information.

They added an open label extension to the study we are on about 5 months ago.

They still don't have any updated lab kits for the visits.

They only just now finished the budget amendment so we have not been paid for any of the open label visits we have done.

It's also just a more challenging protocol than it appears so it's been a real grind to get good subjects.

Click for thumbs down.0Click for thumbs up.1
Hightower Clinical / Note to File Podcast / Existential Dilettante / "Specialization is for insects"
Guest
#6 · May 10, 2022, 2:31 pm
Quote

I will let the CRC know about the lab kit issue. Thanks for the heads up.

Click for thumbs down.0Click for thumbs up.0
Guest
#7 · May 10, 2022, 9:15 pm
Quote

Pfizer just bought Biohaven for 11.6 billion so maybe you can ask for a budget adjustment for the challenging protocol.

Click for thumbs down.0Click for thumbs up.0
brad@brad
184 PostsTopic Author
#8 · May 10, 2022, 9:45 pm
Quote
Quote from Guest on May 10, 2022, 9:15 pm

Pfizer just bought Biohaven for 11.6 billion so maybe you can ask for a budget adjustment for the challenging protocol.

I ju$t $aw that. 🤔

Click for thumbs down.0Click for thumbs up.0
Hightower Clinical / Note to File Podcast / Existential Dilettante / "Specialization is for insects"
Reply
Copyright
Pinnacle Themes